This inventor holds 1 USPTO granted patent. Top assignees: Audion Therapeutics, Eli Lilly and Company. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: Helmuth Hendrikus Gerardus Van Es: Innovator in Notch Pathway Signaling Inhibition
Introduction
Helmuth Hendrikus Gerardus Van Es is a distinguished inventor based in Virac, France. He holds a notable patent that contributes to advancements in medical treatments, particularly focusing on cancer and hearing loss. His innovative work has significant implications for the pharmaceutical industry and healthcare.
Latest Patents
Van Es is the inventor of a patent titled "Notch pathway signaling inhibitor compounds." This patent outlines compounds and their pharmaceutically acceptable salts that are instrumental as Notch pathway signaling inhibitors. These compounds have potential applications in treating various cancers, addressing sensorineural hearing loss caused by auditory hair cell loss, and inducing auditory hair cell generation.
Career Highlights
Throughout his career, Van Es has made significant contributions to the field of pharmaceuticals. He has worked with renowned companies such as Eli Lilly and Company and Audion Therapeutics. His expertise in Notch signaling pathways reflects his commitment to improving human health through innovative solutions.
Collaborations
Van Es has collaborated with several notable coworkers, including Julia Marie Clay and Albert Edge. These partnerships have facilitated a collaborative approach to research and development, fostering an environment of innovation in their respective projects.
Conclusion
Helmuth Hendrikus Gerardus Van Es stands out as an influential inventor whose work on Notch pathway signaling inhibitors holds promise for future therapies. His dedication to advancing medical science through innovation is evident in his patented contributions and collaborative efforts in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile